{
  "report_rows": [
    {
      "kpi": "Comparable diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.03 vs. cons $0.99",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Comparable operating earnings",
      "prediction": "BEAT",
      "answer": "pred ~$446M vs. cons ~$440M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Net sales",
      "prediction": "IN-LINE",
      "answer": "pred ~$3.72B vs. cons $3.69B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Comparable EPS growth",
      "prediction": "LOWER",
      "answer": "guide ~10%+ vs. cons 11.8% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Free cash flow",
      "prediction": "LOWER",
      "answer": "guide >$900M vs. cons ~$925M (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Implied comparable EPS",
      "prediction": "LOWER",
      "answer": "guide ~$1.03 vs. cons $1.06 (2026Q3)",
      "confidence": "LOW"
    },
    {
      "kpi": "Share repurchases",
      "prediction": "UNCHANGED",
      "answer": "guide \u2265$600M vs. cons ~$600M (FY2026)",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": -2.2,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -3.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "A predicted ~$0.04 Q2 EPS beat versus consensus is likely offset by an implicit ~$0.03 Q3 EPS cut from start-up costs, while FY2026 EPS growth remains ~10%+ versus the Street's 11.8%; unchanged cash-flow and buyback targets limit upward revisions and should keep estimates drifting lower after the report.",
  "day5_confidence": "MEDIUM"
}